Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in …

NL Albert, M Weller, B Suchorska, N Galldiks… - Neuro …, 2016 - academic.oup.com
This guideline provides recommendations for the use of PET imaging in gliomas. The review
examines established clinical benefit in glioma patients of PET using glucose (18F-FDG) …

Comparison of amino acid positron emission tomographic radiotracers for molecular imaging of primary and metastatic brain tumors

C Juhász, S Dwivedi, DO Kamson… - Molecular …, 2014 - journals.sagepub.com
Positron emission tomography (PET) is an imaging technology that can detect and
characterize tumors based on their molecular and biochemical properties, such as altered …

Brain tumors: an update on clinical PET research in gliomas

K Herholz - Seminars in nuclear medicine, 2017 - Elsevier
A previous review published in 2012 demonstrated the role of clinical PET for diagnosis and
management of brain tumors using mainly FDG, amino acid tracers, and 18 F …

Integration of dynamic parameters in the analysis of 18F-FDopa PET imaging improves the prediction of molecular features of gliomas

M Ginet, T Zaragori, PY Marie, V Roch… - European journal of …, 2020 - Springer
Abstract Purpose 18 F-FDopa PET imaging of gliomas is routinely interpreted with
standardized uptake value (SUV)-derived indices. This study aimed to determine the added …

Usefulness of 18F-FDOPA PET for the management of primary brain tumors: a systematic review of the literature

F Somme, L Bender, IJ Namer, G Noël, C Bund - Cancer Imaging, 2020 - Springer
Contrast-enhanced magnetic resonance imaging is currently the standard of care in the
management of primary brain tumors, although certain limitations remain. Metabolic imaging …

Diagnostic and grading accuracy of 18F-FDOPA PET and PET/CT in patients with gliomas: a systematic review and meta-analysis

J Xiao, Y Jin, J Nie, F Chen, X Ma - BMC cancer, 2019 - Springer
Background Positron emission tomography (PET) and PET/computed tomography (PET/CT)
imaging with 3, 4-dihydroxy-6-[18 F] fluoro-L-phenylalanine (18 F-FDOPA) has been used in …

The role of [18F]fluorodopa positron emission tomography in grading of gliomas

JR Roach, P Plaha, DR McGowan… - Journal of Neuro-oncology, 2022 - Springer
Purpose Gliomas are the most commonly occurring brain tumour in adults and there remains
no cure for these tumours with treatment strategies being based on tumour grade. All …

18F-FDOPA PET and MRI characteristics correlate with degree of malignancy and predict survival in treatment-naïve gliomas: a cross-sectional study

CB Patel, E Fazzari, A Chakhoyan, J Yao… - Journal of neuro …, 2018 - Springer
Introduction To report the potential value of pre-operative 18 F-FDOPA PET and anatomic
MRI in diagnosis and prognosis of glioma patients. Methods Forty-five patients with a …

Correlation of SUV-derived indices with tumoral aggressiveness of gliomas in static 18F-FDOPA PET: use in clinical practice

L Janvier, P Olivier, M Blonski, O Morel… - Clinical nuclear …, 2015 - journals.lww.com
Purpose Glioma grading is necessary for prognostic evaluation and optimal treatment
decisions. The aims of this study were to establish whether a correlation between 18 F …

Increasing feasibility and utility of 18F-FDOPA PET for the management of glioma

C Bell, N Dowson, S Puttick, Y Gal, P Thomas… - Nuclear medicine and …, 2015 - Elsevier
Introduction Despite radical treatment therapies, glioma continues to carry with it a uniformly
poor prognosis. Patients diagnosed with WHO Grade IV glioma (glioblastomas; GBM) …